Trial Details
TERMINATEDBasic Information
| Clinical ID | c3254 |
|---|---|
| Identifier | NCT02327221 |
| Trial Title | Study Evaluating Ovasave, an Autologous Cell Therapy, in Patients With Active Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn Disease |
| Interventions | DRUG: Ovasave|DRUG: Placebo |
Participant Information
| Sponsor | TxCell |
|---|---|
| City | Innsbruck |
| Country/Region | Austria |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2014-12 |
|---|---|
| Primary Completion Date | 2016-11 |
| Completion Date | 2016-11 |